Wedbush Securities Inc. raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 6.4% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 68,888 shares of the pharmacy operator's stock after buying an additional 4,124 shares during the quarter. Wedbush Securities Inc.'s holdings in Walgreens Boots Alliance were worth $2,611,000 as of its most recent filing with the SEC.
Several other institutional investors also recently bought and sold shares of WBA. Ziegler Capital Management LLC grew its stake in shares of Walgreens Boots Alliance by 9.4% during the 2nd quarter. Ziegler Capital Management LLC now owns 48,103 shares of the pharmacy operator's stock worth $1,823,000 after purchasing an additional 4,135 shares during the period. Keene & Associates Inc. grew its stake in Walgreens Boots Alliance by 0.9% in the 2nd quarter. Keene & Associates Inc. now owns 63,383 shares of the pharmacy operator's stock valued at $2,402,000 after acquiring an additional 566 shares during the last quarter. G&S Capital LLC grew its stake in Walgreens Boots Alliance by 25.2% in the 2nd quarter. G&S Capital LLC now owns 19,629 shares of the pharmacy operator's stock valued at $744,000 after acquiring an additional 3,957 shares during the last quarter. Byrne Asset Management LLC lifted its holdings in Walgreens Boots Alliance by 72.0% in the 2nd quarter. Byrne Asset Management LLC now owns 3,285 shares of the pharmacy operator's stock valued at $125,000 after purchasing an additional 1,375 shares in the last quarter. Finally, Trilogy Capital Inc. lifted its holdings in Walgreens Boots Alliance by 37.7% in the 2nd quarter. Trilogy Capital Inc. now owns 38,281 shares of the pharmacy operator's stock valued at $1,451,000 after purchasing an additional 10,475 shares in the last quarter. 57.33% of the stock is owned by institutional investors and hedge funds.
Get Walgreens Boots Alliance alerts:Walgreens Boots Alliance Stock Down 0.5 %
WBA opened at $31.40 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.43 and a current ratio of 0.78. The business has a 50 day moving average price of $36.70 and a 200 day moving average price of $40.68. The firm has a market cap of $27.14 billion, a P/E ratio of 5.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a twelve month low of $31.23 and a twelve month high of $55.00.
Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last issued its quarterly earnings results on Thursday, June 30th. The pharmacy operator reported $0.96 EPS for the quarter, topping the consensus estimate of $0.95 by $0.01. The company had revenue of $32.60 billion for the quarter, compared to the consensus estimate of $32.23 billion. Walgreens Boots Alliance had a return on equity of 16.20% and a net margin of 4.00%. The company's revenue for the quarter was down 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.51 EPS. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 5.02 EPS for the current year.Walgreens Boots Alliance Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, September 9th. Shareholders of record on Friday, August 19th were given a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 6.11%. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.48. The ex-dividend date was Thursday, August 18th. Walgreens Boots Alliance's dividend payout ratio is 30.97%.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on WBA. Barclays cut their price objective on shares of Walgreens Boots Alliance from $50.00 to $45.00 and set an "equal weight" rating on the stock in a report on Friday, June 24th. Credit Suisse Group dropped their target price on shares of Walgreens Boots Alliance from $52.00 to $43.00 and set a "neutral" rating for the company in a research report on Friday, July 1st. Truist Financial dropped their target price on shares of Walgreens Boots Alliance from $50.00 to $42.00 and set a "hold" rating for the company in a research report on Friday, July 1st. JPMorgan Chase & Co. lowered their price objective on shares of Walgreens Boots Alliance from $52.00 to $45.00 and set a "neutral" rating for the company in a research report on Friday, July 8th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Walgreens Boots Alliance from $44.00 to $38.00 and set a "hold" rating for the company in a research report on Thursday, September 22nd. One investment analyst has rated the stock with a sell rating and nine have given a hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $45.75.
Walgreens Boots Alliance Company Profile
(Get Rating)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Featured Articles
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.